METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer
Shaocheng Zhou, Lijuan Sheng, Lin Zhang, Jianan Zhang, Lei Wang
Topics & Concepts
Downregulation and upregulationGene knockdownDoxorubicinCancer researchChemistryCell cultureMethylationApoptosisMedicineBiologyChemotherapyGeneInternal medicineBiochemistryGeneticsRNA modifications and cancerCancer-related gene regulationCancer-related molecular mechanisms research